Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
- PMID: 23814104
- DOI: 10.1136/bmj.f3646
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
Abstract
Objective: To assess whether lithium has a specific preventive effect for suicide and self harm in people with unipolar and bipolar mood disorders.
Design: Systematic review and meta-analysis.
Data sources: Medline, Embase, CINAHL, PsycINFO, CENTRAL, web based clinical trial registries, major textbooks, authors of important papers and other experts in the discipline, and websites of pharmaceutical companies that manufacture lithium or the comparator drugs (up to January 2013).
Inclusion criteria: Randomised controlled trials comparing lithium with placebo or active drugs in long term treatment for mood disorders.
Review methods: Two reviewers assessed studies for inclusion and risk of bias and extracted data. The main outcomes were the number of people who completed suicide, engaged in deliberate self harm, and died from any cause.
Results: 48 randomised controlled trials (6674 participants, 15 comparisons) were included. Lithium was more effective than placebo in reducing the number of suicides (odds ratio 0.13, 95% confidence interval 0.03 to 0.66) and deaths from any cause (0.38, 0.15 to 0.95). No clear benefits were observed for lithium compared with placebo in preventing deliberate self harm (0.60, 0.27 to 1.32). In unipolar depression, lithium was associated with a reduced risk of suicide (0.36, 0.13 to 0.98) and also the number of total deaths (0.13, 0.02 to 0.76) compared with placebo. When lithium was compared with each active individual treatment a statistically significant difference was found only with carbamazepine for deliberate self harm. Lithium tended to be generally better than the other active comparators, with small statistical variation between the results.
Conclusions: Lithium is an effective treatment for reducing the risk of suicide in people with mood disorders. Lithium may exert its antisuicidal effects by reducing relapse of mood disorder, but additional mechanisms should also be considered because there is some evidence that lithium decreases aggression and possibly impulsivity, which might be another mechanism mediating the antisuicidal effect.
Comment in
-
Lithium and suicide.BMJ. 2013 Jul 10;347:f4449. doi: 10.1136/bmj.f4449. BMJ. 2013. PMID: 23843554 No abstract available.
-
Review: lithium reduces the risk of suicide compared with placebo in people with depression and bipolar disorder.Evid Based Ment Health. 2013 Nov;16(4):112. doi: 10.1136/eb-2013-101493. Epub 2013 Sep 17. Evid Based Ment Health. 2013. PMID: 24046391 No abstract available.
Similar articles
-
Lithium for maintenance treatment of mood disorders.Cochrane Database Syst Rev. 2001;(3):CD003013. doi: 10.1002/14651858.CD003013. Cochrane Database Syst Rev. 2001. PMID: 11687035 Review.
-
Lithium for maintenance treatment of mood disorders.Cochrane Database Syst Rev. 2001;2001(2):CD003013. doi: 10.1002/14651858.CD003013. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2001;(3):CD003013. doi: 10.1002/14651858.CD003013. PMID: 11406061 Free PMC article. Updated. Review.
-
Lithium and suicide in mood disorders: Updated meta-review of the scientific literature.Bipolar Disord. 2017 Nov;19(7):575-586. doi: 10.1111/bdi.12543. Epub 2017 Sep 12. Bipolar Disord. 2017. PMID: 28895269 Review.
-
Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials.Am J Psychiatry. 2005 Oct;162(10):1805-19. doi: 10.1176/appi.ajp.162.10.1805. Am J Psychiatry. 2005. PMID: 16199826 Review.
-
Olanzapine in long-term treatment for bipolar disorder.Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004367. doi: 10.1002/14651858.CD004367.pub2. Cochrane Database Syst Rev. 2009. PMID: 19160237 Review.
Cited by
-
Causality and scientific explanation of artificial intelligence systems in biomedicine.Pflugers Arch. 2024 Oct 29. doi: 10.1007/s00424-024-03033-9. Online ahead of print. Pflugers Arch. 2024. PMID: 39470762 Review.
-
Extended-Release Lithium Treatment for Adolescents with Bipolar Disorder with or Without Comorbid Autism Spectrum Disorder: Protocol of a Longitudinal Prospective Naturalistic Study for the Assessment of Efficacy and Tolerability.J Clin Med. 2024 Oct 17;13(20):6196. doi: 10.3390/jcm13206196. J Clin Med. 2024. PMID: 39458145 Free PMC article.
-
Development of a Clinical Guideline for Suicide Prevention in Psychiatric Patients Based on the ADAPTE Methodology.Psychiatry Investig. 2024 Oct;21(10):1149-1166. doi: 10.30773/pi.2024.0195. Epub 2024 Sep 30. Psychiatry Investig. 2024. PMID: 39344367 Free PMC article.
-
Psychopharmacological Approaches for Neural Plasticity and Neurogenesis in Major Depressive Disorders.Adv Exp Med Biol. 2024;1456:27-48. doi: 10.1007/978-981-97-4402-2_2. Adv Exp Med Biol. 2024. PMID: 39261422 Review.
-
Progress and trends of research on mineral elements for depression.Heliyon. 2024 Jul 31;10(15):e35469. doi: 10.1016/j.heliyon.2024.e35469. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170573 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical